Provided by Tiger Trade Technology Pte. Ltd.

IceCure Medical Ltd.

2.27
-0.1600-6.58%
Post-market: 2.270.00000.00%16:00 EDT
Volume:648.54K
Turnover:1.57M
Market Cap:7.78M
PE:-0.34
High:2.38
Open:2.38
Low:2.18
Close:2.43
52wk High:42.00
52wk Low:2.12
Shares:3.43M
Float Shares:2.20M
Volume Ratio:2.28
T/O Rate:29.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.6592
EPS(LYR):-7.1047
ROE:-228.31%
ROA:-73.88%
PB:0.65
PE(LYR):-0.32

Loading ...

IceCure Medical Secures Exclusive Dutch Distributor for ProSense Cryoablation Systems

TIPRANKS
·
Yesterday

IceCure Signs Exclusive ProSense Distribution Deal with Scovas in Netherlands

Reuters
·
Yesterday

Icecure Signs Exclusive Distribution Agreement for Prosense® Cryoablation Systems in the Netherlands

THOMSON REUTERS
·
Yesterday

IceCure Says West Cancer Center IRB Clears ChoICE Breast Cancer Cryoablation Study

Reuters
·
Aug 20

West Cancer Center Receives Irb Approval to Commence Icecure's Choice Study for Breast Cancer Cryoablation

THOMSON REUTERS
·
Aug 20

IceCure Medical Director David Salton Files Initial Beneficial Ownership Statement

Reuters
·
Aug 17

IceCure Medical Expands 2024 Employee Equity Plan With 2.5 Million Additional Shares

TIPRANKS
·
Aug 15

IceCure Expands 2024 Employee Equity Plan Share Reserve to 2,612,667 Shares

Reuters
·
Aug 15

Lifeward Ltd Q2 Revenue up 16% on Higher ReWalk Personal Exoskeleton Sales

Reuters
·
Aug 14

Hubei Native Yuan Xinyi Awarded Major International Prize Worth Approximately 7 Million Yuan

Deep News
·
Aug 14

IceCure Highlights 5-Year ICE3 Breast Cancer Trial Showing 3.1% Recurrence Rate After Cryoablation

Reuters
·
Aug 13

Israel's MediWound Beats Q2 Revenue Estimates, Reaffirms 2026 Guidance

Reuters
·
Aug 13

Finland's Bioretec H1 Revenue Rises 12%, Loss Narrows

Reuters
·
Aug 13

Oncology Device Maker RenovoRx's Q2 Revenue Surges, Raises FY Outlook

Reuters
·
Aug 13

Icecure Medical Q2 EPS $(1.37) Beats $(1.40) Estimate, Sales $889.000K Miss $1.450M Estimate

Benzinga Earnings
·
Aug 12

Icecure Medical Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Israel's IceCure Medical H1 Revenue Rises on Higher System, Probe Sales

Reuters
·
Aug 12

IceCure Net Loss Widens to USD 8.78 Million in H1 FY26; Revenue Rises 45% to USD 1.82 Million

Reuters
·
Aug 12

Icecure Reports Its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-over-Year

THOMSON REUTERS
·
Aug 12

Icecure Medical H1 Revenue USD 1.8 Million

THOMSON REUTERS
·
Aug 12